Soft-Shell vs Hard-Shell Hyperbaric Chambers: Why the Difference Matters
By OxyPlus — Newcastle's Specialist Hyperbaric Oxygen Therapy Clinicoxyplus.co.uk | Updated July 2026 | 7 min read
If you have been researching hyperbaric oxygen therapy online, you will have noticed something confusing: the same term - HBOT - is used to describe treatments that happen in home portable tents costing a few thousand pounds and treatments that happen in rigid clinical chambers requiring specialist facilities and trained supervision.
These are not the same thing. The difference is not a matter of branding or convenience, it is a matter of physics, oxygen delivery, and whether the outcomes documented in peer-reviewed research are actually achievable at the pressure and oxygen concentration being used.
This post explains exactly what separates soft-shell from hard-shell hyperbaric chambers, what the numbers mean physiologically, and why it matters for anyone making a decision about HBOT.
At OxyPlus, our HBOT clinic in Newcastle, we use medical-grade hard-shell chambers. We think patients deserve to understand why - and to make genuinely informed choices about what they are accessing.
The Basics: What Is the Actual Difference?
Both soft-shell and hard-shell chambers operate on the same principle: increasing atmospheric pressure increases the amount of oxygen that dissolves into blood plasma, delivering oxygen to tissue through a route that doesn't depend on red blood cells.
Beyond that shared principle, the two types diverge significantly.
Soft-shell chambers (also called mild HBOT or portable chambers) are flexible, fabric-based structures, essentially pressurised bags large enough to lie in. They typically operate at 1.3–1.5 ATA. They are pressurised with ambient air (the same 21% oxygen mix we breathe normally) sometimes supplemented by a low-flow oxygen concentrator that raises the concentration modestly. They are designed for home or wellness use, do not require structural modification, and can be deflated and stored.
Hard-shell chambers are rigid structures (steel, aluminium, or thick acrylic) designed to achieve and maintain significantly higher pressures. Clinical hard-shell chambers operate at 2.0–2.5 ATA, with some specialist chambers going higher. They are pressurised with 100% medical-grade oxygen, or with compressed air while the patient breathes 100% oxygen through a dedicated mask or hood. They are fixed installations requiring appropriate ventilation, fire safety protocols, and clinical oversight.
Hard-shell hyperbaric chambers deliver 100% oxygen, while soft chambers only increase oxygen intake from 21% to approximately 26% (unless equipped with oxygen administered through masks or nasal cannulas).
That gap, between 6.3% more oxygen and 100% oxygen, at pressures of 1.3 ATA versus 2.0–2.5 ATA is not a minor technical distinction. It translates into a profound difference in how much oxygen actually reaches your tissue.
The Physics: What Pressure Actually Does to Oxygen Delivery
To understand why pressure matters so much, you need to understand Henry's Law: the amount of a gas dissolved in a liquid is directly proportional to the partial pressure of that gas above the liquid. In the context of HBOT, this means that higher pressure drives more oxygen into blood plasma - and it is that plasma-dissolved oxygen that reaches tissue beyond the reach of compromised blood flow.
The numbers are stark:
Normal breathing at sea level (1 ATA, 21% oxygen): Arterial oxygen level approximately 157 mmHg. Red blood cells are almost fully saturated - there is little capacity to increase oxygen delivery by simply breathing harder.
Soft-shell chamber at 1.3 ATA with ambient air (24% oxygen): Arterial oxygen rises to approximately 230 mmHg - an increase of roughly 46% over normal.
Oxygen mask in ambulance transport (55% oxygen, 1 ATA): Arterial oxygen approximately 418 mmHg - higher than a soft chamber despite the same atmospheric pressure, simply because of the oxygen concentration.
Hard-shell clinical HBOT at 2.4 ATA with 100% oxygen: Arterial oxygen surges to approximately 1,824 mmHg - nearly 12 times the level achievable in a soft-shell chamber, and more than 11 times normal.
The gap between 1.3 ATA and 2.4 ATA is not a minor technical detail.
At 2.4 ATA with 100% oxygen, plasma oxygen levels are high enough to sustain life even without functioning red blood cells. This is why hard-shell HBOT is used in carbon monoxide poisoning and why it can oxygenate tissue through compromised vasculature in ways that soft-shell chambers physically cannot.
The clinical research that demonstrated telomere elongation, senescent cell clearance, brain blood flow improvement, and surgical recovery acceleration was conducted at 2.0–2.5 ATA with 100% oxygen. In most case studies, a medical-grade hard-shell chamber is used to prove the benefit of hyperbaric oxygen therapy.
What Soft-Shell Chambers Can and Cannot Do
This is where honesty matters more than marketing.
Soft-shell chambers are not useless. A 2024 review published in the International Journal of Molecular Sciences confirms that 1.5 ATA breathing 100% oxygen activates meaningful physiological responses at the cellular level. There is some evidence that even lower pressures can provide benefit in certain contexts, a small number of TBI trials found improvements at 1.3 ATA used as a "sham" control, suggesting some effect even at these pressures, though this remains debated.
For recovery athletes wanting to reduce inflammation and soreness after training, soft-shell chambers may offer a degree of benefit. For general wellness use and mild oxygenation, they are a reasonable option. They are accessible, convenient, and considerably cheaper than clinical sessions.
What they cannot do is replicate the physiological conditions that produce the outcomes documented in the clinical research.
Soft-shell chambers are marketed for various off-label wellness uses including post-workout recovery, general wellness, and cognitive performance, but clinical evidence for these applications remains limited.
The FDA has cleared soft-shell portable chambers for only one condition: acute mountain sickness during transport to a medical facility.
Using soft-shell chambers for hyperbaric oxygen therapy can be misleading. Not because they have no effect, but because calling them "HBOT" and presenting them alongside the evidence base for clinical HBOT creates a false equivalence that patients deserve to understand.
Why 100% Oxygen at Clinical Pressure Is Needed for Many Applications
The Telomere and Longevity Research
The landmark Israeli telomere trial, which found over 20% telomere length increases and 10–37% reduction in senescent cells, used 2.0 ATA with 100% oxygen for 60 sessions. Clinical HBOT environments typically operate at 2.0–3.0 ATA; buyers requiring certified clinical pressure levels should consider a hard-shell unit.
Bryan Johnson's documented results - hsCRP eliminated, telomere extension, doubled muscle oxygenation - were achieved with 100% oxygen at 2.0 ATA in a medical-grade hard-shell chamber. He was explicit about this in his published protocol. The results cannot simply be attributed to "hyperbaric oxygen therapy" in a general sense - they were achieved at specific parameters that soft-shell chambers cannot reach.
Surgery Recovery and Wound Healing
The reduction in healing time from 44 to 13 days documented in surgical recovery research; the 8-fold increase in circulating stem cell markers at the 20-session threshold; the angiogenesis that restores blood supply to healing tissue - all of these outcomes are from clinical hard-shell protocols. For patients relying on HBOT to support their recovery from surgery or serious injury, the pressure and oxygen concentration are not optional variables.
Fibromyalgia and Neurological Conditions
The head-to-head fibromyalgia trials that outperformed pregabalin and duloxetine used 2.0 ATA with 100% oxygen. The stroke recovery research that showed neuroplastic reactivation of stunned neurons used 2.0 ATA. The brain health trial that demonstrated measurable cerebral blood flow improvements on MRI used the same parameters.
Scientific research shows that oxygen becomes bacteriostatic at 1.5 ATA - meaning that at levels above 1.5 ATA, oxygen prevents bacterial and fungal growth. With hard-shell hyperbaric oxygen therapy, pressure levels are typically over 2.0 ATA, making it effective in the suppression of bacterial growth.
This anti-infective property, relevant to wound healing, Lyme disease, and post-surgical infection prevention, is simply not achievable below 1.5 ATA.
Safety: Another Dimension Where the Difference Matters
Hard-shell chambers used in clinical settings are regulated medical devices. In the UK and Europe, clinical HBOT facilities operate under CE-marked equipment standards, with appropriate fire safety protocols (NFPA 99 in the US; equivalent standards apply in the UK), trained supervision, and clinical governance.
Hard-sided chambers are recognised medical devices. Hospitals operating hard chambers must comply with appropriate standards for hyperbaric facilities. Even without oxygen tanks, oxygen-enriched, pressurised environments like soft chambers carry elevated fire risk; strict instructions for use adherence, grounding, and clothing and device controls are essential in any chamber type.
The supervision that comes with clinical HBOT is not bureaucracy, it is clinical safety. Having a trained professional present during sessions means that contraindications are identified before they become problems, that pressure changes are managed appropriately for ear and sinus health, and that any adverse responses are addressed immediately.
Home soft-shell chambers, used without clinical oversight, carry risks that the wellness marketing around them rarely acknowledges.
A Practical Guide: What to Ask Before Booking HBOT
If you are considering HBOT here are the questions worth asking:
What pressure does the chamber reach? Clinical therapeutic HBOT operates at 2.0 ATA or above. If the answer is 1.3 or 1.5 ATA, the evidence base for most therapeutic applications does not directly apply.
What oxygen concentration is being delivered? 100% medical-grade oxygen is the standard for clinical HBOT. If the chamber is pressurised with ambient air and supplemented by a low-flow concentrator, the oxygen concentration will be significantly lower.
Is the chamber hard-shell or soft-shell? This is now a meaningful question that any reputable provider should answer directly and honestly.
Who supervises the sessions? Clinical HBOT should be supervised by trained personnel, not simply monitored remotely or left to self-administration.
What is the clinical governance? Consultation before treatment, health screening, and a documented protocol are all markers of a clinically appropriate service.
At OxyPlus in Newcastle, every client receives an initial health consultation before treatment begins. Our chambers are medical-grade hard-shell, operating at 2.4 ATA with 100% oxygen, the same parameters as the published clinical research. Sessions are supervised throughout.
What This Means for You in Newcastle
The reason we are writing this post is not to criticise home soft-shell chambers or dismiss their users. It is because we regularly speak to people in Newcastle and the North East who have either:
Tried a soft-shell chamber and been disappointed by the results, wondering whether HBOT "works"
Are considering purchasing a home chamber after reading about the clinical research - not realising the research was conducted at parameters home chambers cannot achieve
Have seen online content conflating the two types
The clinical evidence for HBOT - the telomere data, the surgical recovery outcomes, the fibromyalgia results, the brain health improvements - was generated at clinical grade. At OxyPlus, that is what we deliver.
Frequently Asked Questions
Q: Is a soft-shell home chamber the same as clinical HBOT? A: No. Soft-shell chambers typically operate at 1.3–1.5 ATA with ambient air, raising arterial oxygen to approximately 230 mmHg. Clinical hard-shell HBOT at 2.4 ATA with 100% oxygen raises arterial oxygen to approximately 1,824 mmHg - nearly 12 times higher. The clinical research demonstrating therapeutic outcomes was conducted at clinical parameters.
Q: Can I get any benefit from a soft-shell home chamber? A: Yes - there is some evidence of benefit at lower pressures, particularly for general recovery and mild oxygenation. However, soft-shell chambers cannot replicate the physiological conditions that produced the published research outcomes for conditions including fibromyalgia, stroke recovery, telomere elongation, and surgical healing.
Q: What pressure does OxyPlus use? A: OxyPlus uses medical-grade hard-shell chambers operating at 2.0 ATA with 100% oxygen - the clinical standard used in the peer-reviewed research.
Q: Are hard-shell chambers safe? A: Yes, when operated in a properly equipped clinical setting with appropriate supervision. Hard-shell HBOT has a well-established safety profile and is a regulated medical device. All OxyPlus clients undergo a health consultation before beginning treatment and sessions are supervised throughout.
Q: Is clinical HBOT much more expensive than a home chamber? A: A quality soft-shell home chamber costs several thousand pounds to purchase. Clinical HBOT is charged per session or as a course. For many people - particularly those seeking a defined therapeutic course rather than indefinite ongoing use - clinical sessions are more cost-effective than a home purchase, with the significant additional benefit of clinical-grade outcomes and appropriate supervision.
Q: Where can I access hard-shell clinical HBOT in Newcastle? A: OxyPlus is Newcastle's specialist clinical HBOT clinic, offering medical-grade hard-shell hyperbaric oxygen therapy with thorough consultations and supervised sessions. We serve clients across Newcastle, Gateshead, Sunderland, Durham, Northumberland, and Teesside. Visit oxyplus.co.uk to book your initial consultation.